COLESTIPOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Colestipol, and when can generic versions of Colestipol launch?
Colestipol is a drug marketed by Impax Labs, Ani Pharms, Edenbridge Pharms, Pharmobedient, Riconpharma Llc, and Zydus Pharms. and is included in seven NDAs.
The generic ingredient in COLESTIPOL is colestipol hydrochloride. There are two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Colestipol
A generic version of COLESTIPOL was approved as colestipol hydrochloride by IMPAX LABS on May 2nd, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COLESTIPOL?
- What are the global sales for COLESTIPOL?
- What is Average Wholesale Price for COLESTIPOL?
Summary for COLESTIPOL
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for COLESTIPOL |
| DailyMed Link: | COLESTIPOL at DailyMed |



